Associations of total osteocalcin with all-cause and cardiovascular mortality in older men: The health in men study

Osteoporosis International

Volumn 23, Issue 2, 2012, Pages 599-606

  Yeap, B B ^a,b   Chubb, S A P ^a,c   Flicker, L ^a,d   McCaul, K A ^d   Ebeling, P R ^e   Hankey, G J ^a   Beilby, J P ^c   Norman, P E ^f  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cardiovascular disease; Male ageing; Mortality; Osteocalcin

Indexed keywords

OSTEOCALCIN;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MORTALITY; OSTEOCALCIN; WESTERN AUSTRALIA;

EID: 84857371265     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-011-1586-1     Document Type: Article

References (36)

1. PV Hauschka JB Lian DE Cole CM Gundberg 1989 Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone Physiol Rev 69 990 1047 2664828 1:CAS:528:DyaL1MXlslWntL0%3D
2. CM Gundberg SD Nieman S Abrams H Rosen 1998 Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin J Clin Endocrinol Metab 83 3258 3266 9745439 10.1210/jc.83.9.3258 1:CAS:528:DyaK1cXmt1egs74%3D
3. NK Lee H Sowa E Hinoi M Ferron JD Ahn C Confavreux R Dacquin PJ Mee MD McKee DY Jung Z Zhang JK Kim F Mauvais-Jarvis P Ducy G Karsenty 2007 Endocrine regulation of energy metabolism by the skeleton Cell 130 456 469 17693256 10.1016/j.cell.2007.05.047 1:CAS:528:DC%2BD2sXptlyntbs%3D
4. M Ferron E Hinoi G Karsenty P Ducy 2008 Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice Proc Natl Acad Sci 105 5266 5270 18362359 10.1073/pnas.0711119105 1:CAS:528:DC%2BD1cXksVOns7Y%3D
5. MK Shea CM Gundberg JB Meigs GE Dallal E Saltzman M Yoshida P Jacques SL Booth 2009 γ-Carboxylation of osteocalcin and insulin resistance in older men and women Am J Clin Nutr 90 1230 1235 19776145 10.3945/ajcn.2009.28151 1:CAS:528:DC%2BD1MXhtlentb7I
6. JI-K HwangY-C KJ Ahn HY Chung 2009 The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced β-cell function in middle-aged male subjects Diabetes Metab Res Rev 25 768 772 10.1002/dmrr.1045
7. I Kanazawa T Yamaguchi M Yamauchi M Yamamoto S Kurioka S Yano T Sugimoto 2009 Adiponectin is associated with changes in bone markers during glycemic control in Type 2 diabetes mellitus J Clin Endocrinol Metab 94 3031 3037 19470634 10.1210/jc.2008-2187 1:CAS:528:DC%2BD1MXpvFGnurs%3D
8. I Kanazawa T Yamaguchi M Yamauchi M Yamamoto S Kurioka S Yano T Sugimoto 2010 Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus Osteoporos Int 10.1007/s00198-010-1184-7
9. I Levinger R Zebaze G Jerums DL Hare S Selig E Seeman 2010 The effect of acute exercise on undercarboxylated osteocalcin in obese men Osteoporos Int 10.1007/s00198-010-1370-7 20734028
10. J-A Im B-P Yu JY Jeon S-H Kim 2008 Relationship between osteocalcin and glucose metabolism Clin Chim Acta 396 66 69 18657532 10.1016/j.cca.2008.07.001 1:CAS:528:DC%2BD1cXhtVKmsrzE
11. JM Kindblom C Ohlsson O Ljunggren MK Karlsson A Tivesten U Smith D Mellstrom 2009 Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men J Bone Miner Res 24 785 791 19063687 10.1359/jbmr.081234 1:CAS:528:DC%2BD1MXlvVWhtLc%3D
12. I Kanazawa T Yamaguchi M Yamamoto M Yamauchi S Kurioka S Yano T Sugimoto 2009 Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes J Clin Endocrinol Metab 94 45 49 18984661 10.1210/jc.2008-1455 1:CAS:528:DC%2BD1MXptVKmtA%3D%3D
13. AG Pittas SS Harris M Eliades P Stark B Dawson-Hughes 2009 Association between serum osteocalcin and markers of metabolic phenotype J Clin Endocrinol Metab 94 827 832 19088165 10.1210/jc.2008-1422 1:CAS:528:DC%2BD1MXjt1Wmsbk%3D
14. U Saleem TH Mosley IJ Kullo 2010 Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome Arterioscler Thromb Vasc Biol 30 1474 1478 20395593 10.1161/ATVBAHA.110.204859 1:CAS:528:DC%2BC3cXnsFGns74%3D
15. BB Yeap SAP Chubb L Flicker KA McCaul PR Ebeling JP Beilby PE Norman 2010 Reduced serum total osteocalcin is associated with metabolic syndrome in older men through its association with hyperglycemia, waist circumference and serum triglycerides Eur J Endocrinol 163 265 272 20501596 10.1530/EJE-10-0414 1:CAS:528:DC%2BC3cXhtFSksrjO
16. CH Saely S Aczel T Marte P Langer G Hoefle H Drexel 2005 The Metabolic Syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients J Clin Endocrinol Metab 90 5698 5703 16091486 10.1210/jc.2005-0799 1:CAS:528:DC%2BD2MXhtFWjt7rI
17. E Bonora S Kiechl J Willeit F Oberhollenzer G Egger JB Meigs RC Bonadonna M Muggeo 2007 Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population Diab Care 30 318 324 10.2337/dc06-0919
18. P Szulc JM Kaufman PD Delmas 2007 Biochemical assessment of bone turnover and bone fragility in men Osteoporos Int 18 1451 1461 17566813 10.1007/s00198-007-0407-z 1:CAS:528:DC%2BD2sXhtFSrt7vP
19. S Khosla S Amin E Orwoll 2008 Osteoporosis in men Endocr Rev 29 441 464 18451258 10.1210/er.2008-0002 1:CAS:528:DC%2BD1cXosVCqu7g%3D
20. M-A Cornier D Dabelea TL Hernandez RC Lindstrom AJ Steig NR Stob RE Van Pelt H Wang RH Eckel 2008 The metabolic syndrome Endocr Rev 29 777 822 18971485 10.1210/er.2008-0024 1:CAS:528:DC%2BD1MXmt1yjtg%3D%3D
21. PE Norman L Flicker OP Almeida GJ Hankey Z Hyde K Jamrozik 2009 Cohort profile: the Health In Men Study (HIMS) Int J Epidemiol 38 48 52 18316347 10.1093/ije/dyn041
22. The Australian Diabetes, Obesity and Lifestyle Study (2000) Diabesity and associated disorders in Australia 2000. International Diabetes Institute, Melbourne
23. CD Holman AJ Bass IL Rouse MS Hobbs 1999 Population-based linkage of health records in Western Australia: development of a health services research linked database Aust N Z J Public Health 23 453 459 10575763 10.1111/j.1467-842X.1999.tb01297.x 1:STN:280:DC%2BD3c%2FktlSitQ%3D%3D
24. ME Charlson P Pompei KL Ales CR MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chr Dis 40 373 383 10.1016/0021-9681(87)90171-8 1:STN:280:DyaL2s7ms1GnsQ%3D%3D
25. M Takahashi K Kushida A Nagano T Inoue 2000 Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay Clin Chim Acta 294 67 76 10727674 10.1016/S0009-8981(99)00251-X 1:CAS:528:DC%2BD3cXhvV2ms78%3D
26. JP Fine RJ Gray 1999 A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 496 509 10.2307/2670170
27. S Greenland 1989 Modeling and variable selection in epidemiologic analysis Am J Public Health 79 340 349 2916724 10.2105/AJPH.79.3.340 1:STN:280:DyaL1M7jt12jsw%3D%3D
28. JM Fernandez-Real M Izquierdo F Ortega E Gorostiaga J Gomez-Ambrosi JM Moreno-Navarrete G Fruhbeck C Martinez F Idoate J Salvador L Forga W Ricart J Ibanez 2009 The relationship of serum osteocalcin to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training J Clin Endocrinol Metab 94 237 245 18854399 10.1210/jc.2008-0270 1:CAS:528: DC%2BD1MXptVKrtg%3D%3D
29. PW Wilson RB D'Agostino H Parise L Sullivan JB Meigs 2005 Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus Circulation 112 3066 3072 16275870 10.1161/CIRCULATIONAHA.105.539528 1:CAS:528:DC%2BD2MXhtF2rtbfL
30. M Ferron J Wei T Yoshizawa A Del Fattore RA DePinho A Teti P Ducy G Karsenty 2010 Insulin signalling in osteoblasts integrates bone remodelling and energy metabolism Cell 142 296 308 20655470 10.1016/j.cell.2010.06.003 1:CAS:528:DC%2BC3cXpsVahsr4%3D
31. K Fulzele RC Riddle DJ DiGirolamo X Cao C Wan D Chen M-C Faugere S Aja MA Hussain JC Bruning TL Clemens 2010 Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition Cell 142 309 319 20655471 10.1016/j.cell.2010.06.002 1:CAS:528:DC%2BC3cXpsVahsr8%3D
32. PN Sambrook CJ Chen L March ID Cameron RG Cumming SR Lord JM Simpson MJ Seibel 2006 High bone turnover is an independent predictor of mortality in the frail elderly J Bone Miner Res 21 549 555 16598375 10.1359/jbmr.060104
33. JS Chen PN Sambrook L March ID Cameron RG Cumming JM Simpson MJ Seibel 2008 Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality Clin Endocrinol 68 290 298 1:CAS:528: DC%2BD1cXjsFemtL8%3D
34. DM Kado WS Browner T Blackwell R Gore SR Cummings 2000 Rate of bone loss is associated with mortality in older women: a prospective study J Bone Miner Res 15 1974 1980 11028450 10.1359/jbmr.2000.15.10.1974 1:STN:280: DC%2BD3cvnslSrsg%3D%3D
35. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, on behalf of the INTERHEART Study Investigators 2004 Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 937 952 10.1016/S0140-6736(04)17018-9
36. ELM Barr AM Tonkin TA Welborn JE Shaw 2009 Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab study Intern Med J 39 49 53 19290982 10.1111/j.1445-5994.2008.01864.x 1:STN:280:DC%2BD1M3htlShtw%3D%3D